Arkolith/Insider Trading/ONCT/Form 4

Wills Robert James

DirectorOncternal Therapeutics, Inc. (ONCT) · full profile →Form 4 · filed Apr 1, 2024
Net Buying
Open-Market Buys
$59K
Open-Market Sells
$0
Net Open-Market Flow
$59K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 28, 2024Buy(P)7K$8.48$59K7K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-24-005154) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML